Infinity Pharmaceuticals Cash End of Year Trend

Infinity Pharmaceuticals Inc -- USA Stock  

USD 2.1  0.18  7.89%

This module enables investors to look at Infinity Pharmaceuticals various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Cost of Revenue of 32.5 M, Gross Profit of 18.7 M or Interest Expense of 5.8 M, but also many exotic indicators such as Long Term Debt to Equity of 0.2339, PPandE Turnover of 9.9897 or Receivables Turnover of 1 K. This module is a perfect complement to use when analyzing Infinity Pharmaceuticals Valuation or Volatility. It can also complement various Infinity Pharmaceuticals Technical models. Please also check analysis of Infinity Pharmaceuticals Correlation with competitors.
Showing smoothed Cash End of Year of Infinity Pharmaceuticals Inc with missing and latest data points interpolated.
Cash End of Year  10 Years Trend  
Increasing
Slightly volatile
 Cash End of Year 
      Timeline 

Infinity Pharmaceuticals Cash End of Year Over Time

2015-12-31  188,170,000 
2016-12-31  188,170,000 
2017-12-31  260,828,947 

Other Fundumenentals

 

Regression Statistics

Arithmetic Mean  109,352,928
Geometric Mean  60,557,037
Coefficient Of Variation  98.64
Mean Deviation  95,591,884
Median  68,114,000
Standard Deviation  107,867,355
Range  291,117,771
R Value  0.82
R Squared  0.68
Significance  0.00098053
Slope  24,652,962

Currently Trending

V   
 NYQ 
Purchased over 20 shares of
a day ago ago
Traded for 107.02
GOOG   
 NMS 
Purchased few shares of
a day ago ago
Traded for 984.45
VMW   
 NYQ 
Purchased over 20 shares of
a day ago ago
Traded for 117.4